Science-led innovation. Patient-focused design.
Aspen’s formulation development brings together pharmaceutical science and practical patient needs. We aim to develop dosage forms that address drug delivery, stability, palatability and ease of administration, with quality guiding every stage.
From conventional formulations to complex delivery platforms, our priorities centre on translating therapeutic requirements into well-designed products.
- 250+Products in our range
- 16Medical specialties
- 6Dosage form categories
Core areas of formulation work
Five areas where our development effort is concentrated.
- 01
Novel drug delivery systems
Exploring delivery approaches that optimise how an active ingredient is released, according to its properties and intended use.
- 02
Taste-masking technologies
Addressing unpleasant taste through suitable formulation techniques, especially for oral liquids and dispersible preparations.
- 03
Solubility and dissolution enhancement
Improving the solubility and dissolution of poorly soluble active ingredients to support product performance.
- 04
Modified-release formulations
Sustained, extended or delayed-release strategies, guided by the active ingredient and the intended dosing profile.
- 05
Bioequivalence and clinical evaluation
Planning evidence-generation pathways, including bioequivalence studies and clinical trials where required, with qualified research partners and subject to regulatory requirements.
Dosage forms we develop
Our formulation development spans pharmaceutical and nutraceutical dosage forms. See these forms in our product range by dosage form.
Oral solids
Tablets, capsules, dispersible formulations and modified-release preparations.
Oral liquids
Solutions, suspensions and emulsions, with attention to palatability and physical stability.
Sterile injectables
Formulation considerations for injectable products, including compatibility, stability and suitability for sterile processing.
Topical preparations
Creams, ointments and gels, with attention to consistency, application and drug release.
Hormonal formulations
Product-specific considerations for dose uniformity, stability and appropriate manufacturing controls.
Nutraceuticals
Formulations designed around ingredient compatibility, stability and convenient administration.
Advanced tablet architectures
Our development priorities also include advanced tablet architectures. The choice of platform is guided by scientific feasibility and the needs of the intended product.
Bilayer tablets
Separate layers that can accommodate different ingredients or release profiles.
Tablet-in-tablet systems
A core tablet within an outer tablet, enabling ingredient separation or tailored release.
Combination formulations
Multiple active ingredients developed with attention to compatibility, stability and dosage requirements.
Five stages from concept to evidence
Understand the product
Evaluate the active ingredient, intended dosage form, patient needs and target product characteristics.
Design the formulation
Select suitable excipients and explore formulation options through structured development trials.
Evaluate performance
Assess relevant attributes such as dissolution, release behaviour, uniformity, compatibility and stability.
Prepare for scale-up
Consider process reproducibility, manufacturing suitability and technology-transfer requirements.
Build the evidence
Define the analytical, stability and study requirements needed to support the applicable development and regulatory pathway.
Practical to manufacture, consistent in performance
A successful formulation must be practical to manufacture and consistent in performance. We emphasise scientifically justified ingredient selection and documented evaluation.
Discuss your formulation requirements